Peroxisome proliferator-activated receptor delta protects against obesity-related glomerulopathy through the P38 MAPK pathway (Q42823021)

8 November 2017

Peroxisome proliferator-activated receptor delta protects against obesity-related glomerulopathy through the P38 MAPK pathway (English)

1 reference

8 November 2017

0 references

Zhencheng Yan

1

1 reference

8 November 2017

Yinxing Ni

2

1 reference

8 November 2017

Peijian Wang

3

1 reference

8 November 2017

Jian Chen

4

1 reference

8 November 2017

Hongbo He

5

1 reference

8 November 2017

Jing Sun

6

1 reference

8 November 2017

Tingbing Cao

7

1 reference

8 November 2017

Jing Chen

8

1 reference

8 November 2017

Zhigang Zhao

9

1 reference

8 November 2017

Zhidan Luo

10

1 reference

8 November 2017

Lin Chen

11

1 reference

8 November 2017

Daoyan Liu

12

1 reference

8 November 2017

Zhiming Zhu

13

1 reference

8 November 2017

1 March 2013

1 reference

8 November 2017

1 reference

8 November 2017

21

1 reference

8 November 2017

3

1 reference

8 November 2017

538-545

1 reference

8 November 2017

1 reference

The disease burden associated with overweight and obesity

21 January 2018

1 reference

Combined renal effects of overweight and hypertension.

21 January 2018

1 reference

Obesity, salt intake, and renal perfusion in healthy humans.

21 January 2018

1 reference

Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents

21 January 2018

1 reference

Cellular lipid metabolism and the role of lipids in progressive renal disease

21 January 2018

1 reference

PPARs and the kidney in metabolic syndrome

21 January 2018

1 reference

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

21 January 2018

1 reference

PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.

21 January 2018

1 reference

PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis

21 January 2018

1 reference

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells

21 January 2018

1 reference

Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure

21 January 2018

1 reference

Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.

21 January 2018

1 reference

Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice

21 January 2018

1 reference

PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase

21 January 2018

1 reference

Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats

21 January 2018

1 reference

Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta

21 January 2018

1 reference

Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity

21 January 2018

1 reference

Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes

21 January 2018

1 reference

Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.

21 January 2018

1 reference

Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress

21 January 2018

1 reference

Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats

21 January 2018

1 reference

Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice.

21 January 2018

1 reference

Effects of alpha-lipoic acid on transforming growth factor beta1-p38 mitogen-activated protein kinase-fibronectin pathway in diabetic nephropathy

21 January 2018

1 reference

Mitogen-activated protein kinases and transcriptional responses in renal injury and repair

21 January 2018

1 reference

Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity

21 January 2018

1 reference

Peroxisome proliferator-activated receptor {delta} activators induce IL-8 expression in nonstimulated endothelial cells in a transcriptional and posttranscriptional manner

21 January 2018

1 reference

Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome

21 January 2018

1 reference

mRNA expression for insulin-like growth factor 1, receptors of growth hormone and IGF-1 and transforming growth factor-beta in the kidney and liver of Zucker rats

21 January 2018

1 reference

IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride

21 January 2018

1 reference

Peroxisome proliferator-activated receptor-delta induces cell proliferation by a cyclin E1-dependent mechanism and is up-regulated in thyroid tumors

21 January 2018

1 reference

PPARdelta agonist-mediated ROS stimulates mouse embryonic stem cell proliferation through cooperation of p38 MAPK and Wnt/beta-catenin

21 January 2018

1 reference

The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/OBY.20103

1 reference

8 November 2017

1 reference